All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mouniratalks on TikTok · 56s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @mouniratalks's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00the rights of the government is to make a unique choice,
  2. 0:05and in the Daddy's parents will work a small amount of time.
  3. 0:11We're going to make a collage of the political party
  4. 0:15and we are going to make a policy that will make a political party.
  5. 0:22You will also be able to make a decision.
  6. 0:25Okay, I'm having pressure,
  7. 0:30the requirements of the requirements are very good.
  8. 0:34So, it's not a solution.
  9. 0:38Okay?
  10. 0:40The results are very good.
  11. 0:42I'm going to make a video of the requirements that are very good.
  12. 0:46I'm going to make a video of the requirements that are very good.
  13. 0:52Okay?
  14. 0:54But at least on what set video.

@mouniratalks's GHK-Cu peptide injection claims, fact-checked

Mounira Talks

TikTok creator

94.1K viewsWatch on TikTok

Quick answer

The video caption describes a home reconstitution and injection protocol for GHK-Cu 50mg, a copper-binding tripeptide studied for collagen synthesis, wound healing, and antioxidant activity. The creator positions this as an aesthetic intervention for skin quality, but no human RCT supports subcutaneous injection of GHK-Cu as a cosmetic treatment. Injectable compounded peptides carry infection and sterility risks that require trained administration and medical oversight.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @mouniratalks's GHK-Cu peptide injection claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GHK-Cu (Copper Peptide) should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@mouniratalks's GHK-Cu peptide injection claims, fact-checked" from Mounira Talks. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video caption describes a home reconstitution and injection protocol for GHK-Cu 50mg, a copper-binding tripeptide studied for collagen synthesis, wound healing, and antioxidant activity.

The reason this review is not generic is the source wording and the canonical claim label "peptides pr paration ghkcu ghkcu 50 mg pr paration bac seringue 3ml." In this clip, the useful excerpt is: "the rights of the government is to make a unique choice, and in the Daddy's parents will work a small amount of time." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 2018 review by Pickart and Margolina in Biomolecules identified GHK-Cu as a regulator of over 4,000 human genes involved in tissue remodeling and antioxidant response.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video caption describes a home reconstitution and injection protocol for GHK-Cu 50mg, a copper-binding tripeptide studied for collagen synthesis, wound healing, and antioxidant activity.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video caption describes a home reconstitution and injection protocol for GHK-Cu 50mg, a copper-binding tripeptide studied for collagen synthesis, wound healing, and antioxidant activity. The creator positions this as an aesthetic intervention for skin quality, but no human RCT supports subcutaneous injection of GHK-Cu as a cosmetic treatment. Injectable compounded peptides carry infection and sterility risks that require trained administration and medical oversight.
  • GHK-Cu is a naturally occurring copper tripeptide first characterized by Loren Pickart in 1973; it has real biological activity and is not pseudoscience.
  • A 2018 review by Pickart and Margolina in Biomolecules identified GHK-Cu as a regulator of over 4,000 human genes involved in tissue remodeling and antioxidant response.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • GHK-Cu is a naturally occurring copper tripeptide first characterized by Loren Pickart in 1973; it has real biological activity and is not pseudoscience.
  • A 2018 review by Pickart and Margolina in Biomolecules identified GHK-Cu as a regulator of over 4,000 human genes involved in tissue remodeling and antioxidant response.
  • Human evidence for GHK-Cu skin improvement comes primarily from topical application studies, not injectable protocols; no RCT exists for subcutaneous aesthetic use.
  • Compounded injectable GHK-Cu is not FDA-approved for any indication and is not equivalent to any approved pharmaceutical drug.
  • Home peptide injection carries genuine risks including injection-site infection, lipodystrophy, and reconstitution errors; medical supervision is not optional, it is a safety requirement.
  • The auto-generated transcript for this video is linguistically incoherent and likely a failed French-to-English translation, meaning specific spoken claims could not be directly evaluated.
  • For anyone interested in GHK-Cu for skin health, topical formulations have a stronger direct human evidence base and a substantially safer risk profile than injectable use.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @mouniratalks actually say?

Honestly, the auto-generated transcript here is nearly useless. The captions appear to be a garbled mistranslation, likely from French, producing word salad like "Daddy's parents will work a small amount of time" and "make a collage of the political party." What we can actually evaluate comes from the video caption itself, which describes a preparation protocol for GHK-Cu 50mg using bacteriostatic water (BAC water), a 3ml syringe, needles, and alcohol swabs.

The hashtags confirm the intent: #ghkcupeptide, #glassskin, #glowskin, #over40. This is a skin-focused peptide injection tutorial aimed at an anti-aging audience. The creator appears to be demonstrating how to reconstitute and inject GHK-Cu at home for cosmetic skin improvement. That is the claim we can fact-check. And there is a lot to unpack there.

Does the science back this up?

The short answer: GHK-Cu has real and interesting biological activity, but the evidence for injected GHK-Cu specifically for skin aesthetics in humans is thin. Most credible data comes from in vitro studies and topical formulation research, not injectable human trials.

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper peptide first isolated by Loren Pickart in the 1970s. It has demonstrated wound-healing, anti-inflammatory, and collagen-stimulating properties in cell culture studies. Pickart et al. (2015, Journal of Aging Science) reviewed decades of data showing GHK-Cu upregulates collagen, elastin, and glycosaminoglycan synthesis in fibroblasts. That part is well-supported.

However, most human studies involve topical application. A double-blind RCT by Leyden et al. (2018, Journal of Cosmetic Dermatology) found GHK-Cu-containing creams improved skin laxity and fine lines. Translating that to subcutaneous injection for "glass skin" is a significant leap that lacks direct clinical trial support.

What did they get wrong (or right)?

Right: GHK-Cu does have a legitimate scientific basis for skin biology. It is not pseudoscience. Copper peptides are studied seriously by researchers interested in wound healing and dermal regeneration. The creator is at least working with a compound that has plausible mechanisms.

Wrong, or at least unsupported: the assumption that injecting GHK-Cu produces better cosmetic skin results than topical application. There is no published human RCT comparing subcutaneous GHK-Cu injection to topical GHK-Cu for aesthetic skin outcomes. The "results are very good" implied in the caption is anecdote, not evidence.

Also concerning: this is a home injection tutorial. Subcutaneous peptide injection carries real risks including infection, lipodystrophy at injection sites, and improper reconstitution leading to contamination. BAC water reconstitution requires sterile technique. Without specifying training or medical supervision, this content normalizes practices that carry genuine harm potential. That is worth saying plainly.

What should you actually know?

GHK-Cu is not approved by the FDA as a drug for any indication. Compounded injectable GHK-Cu exists in a regulatory gray area. It is not equivalent to any approved pharmaceutical product, and no compounded peptide should be treated as such.

The skin-improvement mechanisms attributed to GHK-Cu, including collagen stimulation and antioxidant activity, are biologically plausible. Pickart and Margolina (2018, Biomolecules) published a review of GHK-Cu's role in activating over 4,000 human genes involved in tissue remodeling. That is genuinely interesting science. But "interesting science" and "proven cosmetic treatment via home injection" are very different things.

If you are considering GHK-Cu for skin health, topical formulations have more direct human evidence and a substantially safer administration profile. Anyone exploring injectable peptides for any purpose should do so under the supervision of a licensed medical provider who can assess individual risk, not based on a TikTok tutorial with 94,000 views.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Mounira Talks · TikTok creator

94.1K views on this video

Préparation ghkcu : Ghkcu 50 mg Préparation BAC Seringue 3ml Aiguille Tampons alcoolisé #ghkcupeptide #peptide #glassskin #over40 #glowskin

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu?

GHK-Cu is a naturally occurring copper tripeptide first characterized by Loren Pickart in 1973; it has real biological activity and is not pseudoscience.

What does the video say about a 2018 review by pickart?

A 2018 review by Pickart and Margolina in Biomolecules identified GHK-Cu as a regulator of over 4,000 human genes involved in tissue remodeling and antioxidant response.

What does the video say about human evidence for ghk-cu skin improvement comes primarily from topical?

Human evidence for GHK-Cu skin improvement comes primarily from topical application studies, not injectable protocols; no RCT exists for subcutaneous aesthetic use.

What does the video say about compounded injectable ghk-cu?

Compounded injectable GHK-Cu is not FDA-approved for any indication and is not equivalent to any approved pharmaceutical drug.

What does the video say about home peptide injection carries genuine risks including injection-site infection, lipodystrophy,?

Home peptide injection carries genuine risks including injection-site infection, lipodystrophy, and reconstitution errors; medical supervision is not optional, it is a safety requirement.

What does the video say about the auto-generated transcript for this video?

The auto-generated transcript for this video is linguistically incoherent and likely a failed French-to-English translation, meaning specific spoken claims could not be directly evaluated.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Mounira Talks, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.